The coronavirus illness 2019 (COVID-19) pandemic, brought on by extreme acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is threatening folks’s lives and impacting their well being. It’s nonetheless unclear whether or not folks engaged in bodily exercise are at an elevated danger of SARS-CoV-2 an infection and extreme types of COVID-19.
To be able to present knowledge to assist reply this query, we, subsequently, investigated the results of endurance coaching on the degrees of host proteins concerned in SARS-CoV-2 an infection in mice. Eight-week-old C57BL/6J mice have been subjected to treadmill operating (17-25 m/min, 60-90 min, 5 classes/week, eight weeks).
After the intervention, the degrees of angiotensin-converting enzyme 2 (ACE2; host receptor for SARS-CoV-2), transmembrane protease serine 2 (TMPRSS2; host protease priming fusion of SARS-CoV-2 to host cell membranes), FURIN (host protease that promotes binding of SARS-CoV-2 to host receptors), and Neuropilin-1 (host coreceptor for SARS-CoV-2) have been measured in 10 organs that SARS-CoV-2 can infect (larynx, trachea, lung, coronary heart, jejunum, ileum, colon, liver, kidney, and testis).
Six organs (coronary heart, lung, jejunum, liver, trachea, and ileum) confirmed modifications within the ranges of at the very least one of many proteins. Endurance coaching elevated ACE2 ranges in coronary heart (+66.4%), lung (+37.1%), jejunum (+24.7%) and liver (+27.4%), and FURIN in liver (+17.9%) tissue. In distinction, endurance coaching decreased Neuropilin-1 ranges in liver (-39.7%), trachea (-41.2%), and ileum (-39.7%), and TMPRSS2 in lung (-11.3%). Taken collectively, endurance coaching altered the degrees of host proteins concerned in SARS-CoV-2 cell entry in an organ-dependent method.
A Multiplex Noninvasive Salivary Antibody Assay for SARS-CoV-2 An infection and Its Software in a Inhabitants-Based mostly Survey by Mail
Noninvasive salivary antibody immunoassays can allow low-cost epidemiological surveillance of infections. This research concerned creating and validating a multiplex suspension immunoassay on the Luminex platform to measure immunoglobulin G (IgG) responses to extreme acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleocapsid and spike (S) proteins, and the spike protein’s S1 and S2 subunits and receptor binding area.
A number of variations of those recombinant proteins acquired from industrial and noncommercial sources have been evaluated. Assay growth and validation utilized saliva and serum samples from coronavirus illness 2019 (COVID-19) instances procured from industrial sources and damaging controls from a prepandemic survey.
Saliva was additionally collected in an illustration survey by mail involving grownup people in the US who have been recognized with SARS-CoV-2 an infection 15 to 80 days previous to pattern assortment. The survey had an 83% legitimate pattern return price (192 samples from 38 states).
Most COVID-19 instances (93%) reported mildly symptomatic or asymptomatic infections. The ultimate salivary assay primarily based on the best-performing spike and nucleocapsid proteins had a sensitivity of 87.1% (95% bootstrap confidence interval, 82.1 to 91.7%) and specificity of 98.5% (95.Zero to 100%) utilizing 227 and 285 saliva samples, respectively.
The identical assay had 95.9% (92.eight to 98.9%) sensitivity and 100% (98.Four to 100%) specificity in serum (174 and 285 serum samples, respectively). Salivary and serum antibody responses to spike and nucleocapsid proteins have been strongly correlated in 22 paired samples (r = 0.88 and r = 0.80, respectively). Antibody responses peaked at roughly 50 days postonset; higher sickness severity was related to stronger responses.
This research demonstrated {that a} salivary antibody assay can be utilized in large-scale inhabitants surveys by mail to raised characterize public well being impacts of COVID-19. IMPORTANCE Given the big impacts of the COVID-19 pandemic, creating instruments for inhabitants surveillance of an infection is of paramount significance.
This text describes the event of a multiplex immunoassay on a Luminex platform to measure salivary immunoglobulin G responses to the spike protein, its two subunits and receptor binding area, and the nucleocapsid protein of SARS-CoV-2. The assay validation utilized serum and saliva samples from prepandemic controls and up to date COVID-19 instances.
A survey by mail focusing on current COVID-19 instances throughout the US additionally demonstrated the utility of secure, at-home self-collection of saliva. By incorporating a number of SARS-CoV-2 proteins, this assay might differentiate responses to pure SARS-CoV-2 infections from responses to most vaccines.
Software of this noninvasive immunoassay in COVID-19 surveillance will help present estimates of cumulative incidence charges of symptomatic and asymptomatic infections in varied communities and subpopulations, temporal patterns of antibody responses, and danger components for an infection.
Roborovski hamster (Phodopus roborovskii) pressure SH101 as a systemic an infection mannequin of SARS-CoV-2
Extreme acute respiratory syndrome CoV-2 (SARS-CoV-2) is presently inflicting a worldwide menace with its unusually excessive transmission charges and fast evolution into various strains. In contrast to typical respiratory viruses, SARS-CoV-2 ceaselessly causes systemic an infection by breaking the boundaries of the respiratory methods.
The event of animal fashions recapitulating the medical manifestations of COVID-19 is of utmost significance not just for the event of vaccines and antivirals but additionally for understanding the pathogenesis. Nonetheless, there has not been developed an animal mannequin for systemic an infection of SARS-CoV-2 representing most features of the medical manifestations of COVID-19 with systemic signs.
Right here we report {that a} Roborovski hamster pressure SH101, a laboratory inbred hamster pressure of P. roborovskii, displayed most signs of systemic an infection upon SARS-CoV-2 an infection as within the case of the human counterpart, in contrast to present COVID-19 animal fashions.
Roborovski hamster pressure SH101 post-infection of SARS-CoV-2 represented most medical signs of COVID-19 resembling snuffling, labored respiratory, dyspnea, cough, hunched posture, progressive weight reduction, ruffled fur, and excessive fever following shaking chills.
Histological examinations additionally revealed preliminary right-predominated pneumonia in addition to slight organ damages within the mind and liver, manifesting systemic COVID-19 instances. Contemplating the advantage of a small animal in addition to its medical manifestations of SARS-CoV-2 an infection in human, this hamster mannequin appears to supply a perfect software to research COVID-19.
A mathematical mannequin for the dynamics of SARS-CoV-2 virus utilizing the Caputo-Fabrizio operator
The pandemic of SARS-CoV-2 virus stays a urgent problem with unpredictable traits which unfold worldwide via human interactions. The present research is specializing in the investigation and evaluation of a fractional-order epidemic mannequin that discusses the temporal dynamics of the SARS-CoV-2 virus in a group. It’s well-known that symptomatic and asymptomatic people have a significant impact on the dynamics of the SARS-CoV-2 virus subsequently, we divide the whole inhabitants into inclined, asymptomatic, symptomatic, and recovered teams of the inhabitants.
Additional, we assume that the vaccine confers everlasting immunity as a result of a number of vaccinations have commenced throughout the globe. The brand new fractional-order mannequin for the transmission dynamics of SARS-CoV-2 virus is formulated by way of the Caputo-Fabrizio fractional-order method with the upkeep of dimension in the course of the technique of fractionalization.
The speculation of mounted level will probably be used to point out that the proposed mannequin possesses a novel answer whereas the well-posedness (bounded-ness and positivity) of the fractional-order mannequin options are mentioned.
SARS-Associated Coronavirus Spike Mosaic S (C) Recombinant (SARS Mosaic S (C) ) |
|
PT_42025 |
Novatein Biosciences, Inc. |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
SARS-Associated Coronavirus Spike Mosaic S (M) Recombinant (SARS Mosaic S (M) ) |
|
PT_42026 |
Novatein Biosciences, Inc. |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
SARS-Associated Coronavirus Spike Mosaic S (N) Recombinant (SARS Mosaic S (N) ) |
|
PT_42027 |
Novatein Biosciences, Inc. |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
Recombinant SARS Mosaic S(C) Antigen |
|
VAC-0278 |
Creative BioMart |
0.5ml |
EUR 798.4 |
|
Description: Protein |
Recombinant SARS Mosaic S(M) Antigen |
|
VAC-0279 |
Creative BioMart |
0.5ml |
EUR 798.4 |
|
Description: Protein |
SARS Coronavirus Mosaic Recombinant protein |
|
39-110 |
ProSci |
0.05 mg |
EUR 556.8 |
|
Description: SARS or severe acute respiratory syndrome is a lethal kind of pneumonia generated by coronavirus. Coronaviruses are a family of viruses that causes a mild respiratory tract infection is a large type of creatures such as humans, pigs, cows, mice, cats etc. up to this day, the origin of the coronavirus is still unknown. |
SARS Associated Spike Mosaic S Protein |
|
20-abx260156 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
|
SARS Associated Spike Mosaic S Protein |
|
abx260156-20g |
Abbexa |
20 µg |
EUR 950 |
SARS Associated Spike Mosaic S Protein |
|
abx260156-5g |
Abbexa |
5 µg |
EUR 350 |
Recombinant SARS SARS Mosaic S(C) Protein, Untagged, E.coli-1mg |
|
QP13420-1mg |
EnQuireBio |
1mg |
EUR 1273.2 |
Recombinant SARS SARS Mosaic S(M) Protein, Untagged, E.coli-1mg |
|
QP13421-1mg |
EnQuireBio |
1mg |
EUR 1273.2 |
Recombinant SARS SARS Mosaic S(N) Protein, Untagged, E.coli-1mg |
|
QP13422-1mg |
EnQuireBio |
1mg |
EUR 1273.2 |
Recombinant SARS SARS Mosaic S(C) Protein, Untagged, E.coli-100ug |
|
QP13420-100ug |
EnQuireBio |
100ug |
EUR 261.6 |
Recombinant SARS SARS Mosaic S(C) Protein, Untagged, E.coli-500ug |
|
QP13420-500ug |
EnQuireBio |
500ug |
EUR 795.6 |
Recombinant SARS SARS Mosaic S(M) Protein, Untagged, E.coli-100ug |
|
QP13421-100ug |
EnQuireBio |
100ug |
EUR 261.6 |
Recombinant SARS SARS Mosaic S(M) Protein, Untagged, E.coli-500ug |
|
QP13421-500ug |
EnQuireBio |
500ug |
EUR 795.6 |
Recombinant SARS SARS Mosaic S(N) Protein, Untagged, E.coli-100ug |
|
QP13422-100ug |
EnQuireBio |
100ug |
EUR 261.6 |
Recombinant SARS SARS Mosaic S(N) Protein, Untagged, E.coli-500ug |
|
QP13422-500ug |
EnQuireBio |
500ug |
EUR 795.6 |
Recombinant SARS Associated Spike Mosaic S |
|
MBS143141-01mg |
MyBiosource |
0.1mg |
EUR 330 |
Recombinant SARS Associated Spike Mosaic S |
|
MBS143141-05mg |
MyBiosource |
0.5mg |
EUR 825 |
Recombinant SARS Associated Spike Mosaic S |
|
MBS143141-1mg |
MyBiosource |
1mg |
EUR 1260 |
Recombinant SARS Associated Spike Mosaic S |
|
MBS143141-5x1mg |
MyBiosource |
5x1mg |
EUR 5345 |
SARS Associated Spike Mosaic S(M) Protein |
|
20-abx260155 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
|
SARS Associated Spike Mosaic S(M) Protein |
|
abx260155-20g |
Abbexa |
20 µg |
EUR 950 |
SARS Associated Spike Mosaic S(M) Protein |
|
abx260155-5g |
Abbexa |
5 µg |
EUR 350 |
SARS Associated Spike Mosaic S(N) Protein |
|
20-abx260157 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
|
SARS Associated Spike Mosaic S(N) Protein |
|
abx260157-20g |
Abbexa |
20 µg |
EUR 950 |
SARS Associated Spike Mosaic S(N) Protein |
|
abx260157-5g |
Abbexa |
5 µg |
EUR 350 |
Recombinant SARS Associated Spike Mosaic S(N) |
|
7-07093 |
CHI Scientific |
100µg |
Ask for price |
Recombinant SARS Associated Spike Mosaic S(N) |
|
7-07094 |
CHI Scientific |
500µg |
Ask for price |
Recombinant SARS Associated Spike Mosaic S(N) |
|
7-07095 |
CHI Scientific |
1000µg |
Ask for price |
Recombinant SARS Associated Spike Mosaic S(M) |
|
7-07096 |
CHI Scientific |
100µg |
Ask for price |
Recombinant SARS Associated Spike Mosaic S(M) |
|
7-07097 |
CHI Scientific |
500µg |
Ask for price |
Recombinant SARS Associated Spike Mosaic S(M) |
|
7-07098 |
CHI Scientific |
1000µg |
Ask for price |
Recombinant SARS Associated Spike Mosaic S© |
|
7-07099 |
CHI Scientific |
100µg |
Ask for price |
Recombinant SARS Associated Spike Mosaic S© |
|
7-07100 |
CHI Scientific |
500µg |
Ask for price |
Recombinant SARS Associated Spike Mosaic S© |
|
7-07101 |
CHI Scientific |
1000µg |
Ask for price |
SARS Associated Spike Mosaic S(M) (Recombinant) |
|
22060688-1 |
Bio-WORLD |
100 µg |
EUR 344.89 |
SARS Associated Spike Mosaic S(N) (Recombinant) |
|
22060689-1 |
Bio-WORLD |
100 µg |
EUR 344.89 |
SARS Associated Spike Mosaic S(C) (Recombinant) |
|
22060690-1 |
Bio-WORLD |
100 µg |
EUR 344.89 |
Recombinant SARS Associated Spike Mosaic S(M) |
|
MBS143140-01mg |
MyBiosource |
0.1mg |
EUR 330 |
Recombinant SARS Associated Spike Mosaic S(M) |
|
MBS143140-05mg |
MyBiosource |
0.5mg |
EUR 825 |
Recombinant SARS Associated Spike Mosaic S(M) |
|
MBS143140-1mg |
MyBiosource |
1mg |
EUR 1260 |
Recombinant SARS Associated Spike Mosaic S(M) |
|
MBS143140-5x1mg |
MyBiosource |
5x1mg |
EUR 5345 |
Recombinant SARS Associated Spike Mosaic S(N) |
|
MBS143142-01mg |
MyBiosource |
0.1mg |
EUR 330 |
Recombinant SARS Associated Spike Mosaic S(N) |
|
MBS143142-05mg |
MyBiosource |
0.5mg |
EUR 825 |
Recombinant SARS Associated Spike Mosaic S(N) |
|
MBS143142-1mg |
MyBiosource |
1mg |
EUR 1260 |
Recombinant SARS Associated Spike Mosaic S(N) |
|
MBS143142-5x1mg |
MyBiosource |
5x1mg |
EUR 5345 |
Recombinant (E.Coli) SARS Associated Spike Mosaic S |
|
RP-1422 |
Alpha Diagnostics |
100 ug |
EUR 343.2 |
Recombinant (E.Coli) SARS Associated Spike Mosaic S |
|
RP-1423 |
Alpha Diagnostics |
100 ug |
EUR 343.2 |
Recombinant (E.Coli) SARS Associated Spike Mosaic S |
|
RP-1424 |
Alpha Diagnostics |
100 ug |
EUR 343.2 |
Recombinant SARS Spike Mosaic Antigen, His-tagged |
|
VAC-0281 |
Creative BioMart |
0.5ml |
EUR 798.4 |
|
|
|
Description: Protein |
SARS-CoV-2 Mosaic Recombinant protein His Tag |
|
ICOV2MOSAICRHIS50UG |
Innovative research |
each |
EUR 648 |
|
|
|
Description: SARS-CoV-2 Mosaic Recombinant protein His Tag |
SARS-CoV-2 Mosaic Recombinant protein His Tag |
|
MBS8430824-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
SARS Coronavirus Spike Mosaic Recombinant protein (Center) |
|
39-122 |
ProSci |
0.1 mg |
EUR 556.8 |
|
Description: SARS Coronavirus is an enveloped virus containing three outer structural proteins, namely the membrane (M), envelope (E), and spike (S) proteins. Spike (S)-glycoprotein of the virus interacts with a cellular receptor and mediates membrane fusion to allow viral entry into susceptible target cells. Accordingly, S-protein plays an important role in virus infection cycle and is the primary target of neutralizing antibodies. |
SARS Coronavirus Spike Glycoprotein (S1) Mosaic (E. coli) |
|
REC31842-100 |
The Native Antigen Company |
0.1 |
EUR 415.88 |
|
|
|
Description: Recombinant protein manufactured in E. coli. Contains amino acids 408-470 and 540-573 of the Spike protein immunodominant region. Immunoreactive with sera from SARS-infected individuals. |
SARS Coronavirus Spike Glycoprotein (S1) Mosaic (E. coli) |
|
REC31842-500 |
The Native Antigen Company |
0.5 |
EUR 1560.53 |
|
|
|
Description: Recombinant protein manufactured in E. coli. Contains amino acids 408-470 and 540-573 of the Spike protein immunodominant region. Immunoreactive with sera from SARS-infected individuals. |
Recombinant SARS Spike Mosaic Protein S (N-Terminal) |
|
VAng-Lsx0073-inquire |
Creative Biolabs |
inquire |
Ask for price |
|
Description: SARS spike mosaic protein S (N-terminal), recombinant protein from E. coli. |
SARS-Associated Coronavirus Spike Mosaic S (M) Recombinant |
|
rAP-5473 |
Angio Proteomie |
Inquiry |
Ask for price |
SARS-Associated Coronavirus Spike Mosaic S(C) Recombinant |
|
rAP-5474 |
Angio Proteomie |
Inquiry |
Ask for price |
SARS-Associated Coronavirus Spike Mosaic S (N) Recombinant |
|
rAP-5475 |
Angio Proteomie |
Inquiry |
Ask for price |
SARS Coronavirus Spike Mosaic Recombinant protein (C-terminus) |
|
39-123 |
ProSci |
0.1 mg |
EUR 556.8 |
|
Description: SARS Coronavirus is an enveloped virus containing three outer structural proteins, namely the membrane (M), envelope (E), and spike (S) proteins. Spike (S)-glycoprotein of the virus interacts with a cellular receptor and mediates membrane fusion to allow viral entry into susceptible target cells. Accordingly, S-protein plays an important role in virus infection cycle and is the primary target of neutralizing antibodies. |
SARS Coronavirus Spike Mosaic Recombinant protein (N-terminus) |
|
39-124 |
ProSci |
0.1 mg |
EUR 556.8 |
|
Description: SARS Coronavirus is an enveloped virus containing three outer structural proteins, namely the membrane (M), envelope (E), and spike (S) proteins. Spike (S)-glycoprotein of the virus interacts with a cellular receptor and mediates membrane fusion to allow viral entry into susceptible target cells. Accordingly, S-protein plays an important role in virus infection cycle and is the primary target of neutralizing antibodies. |
Recombinant SARS Spike Mosaic S Protein (aa 408-470, 540-573) |
|
VAng-Lsx0056-inquire |
Creative Biolabs |
inquire |
Ask for price |
|
Description: Recombinant SARS-CoV Spike protein containing 408-470, 540-573 amino acids immunodominant regions was expressed in E. coli and purified by proprietary chromatographic technique. |
SARS-CoV-2 Spike Mosaic Recombinant protein (Center) Liquid |
|
ICOV2SPIKEMOSAICRC100UG |
Innovative research |
each |
EUR 648 |
|
|
|
Description: SARS-CoV-2 Spike Mosaic Recombinant protein (Center) Liquid |
SARS-CoV-2 Spike Mosaic Recombinant protein (Center) Liquid |
|
MBS8430890-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
SARS-CoV-2 Spike E Mosaic Recombinant protein His Tag |
|
ICOV2SPIKEEMOSAICRHIS50UG |
Innovative research |
each |
EUR 648 |
|
|
|
Description: SARS-CoV-2 Spike E Mosaic Recombinant protein His Tag |
SARS-CoV-2 Spike E Mosaic Recombinant protein His Tag |
|
MBS8430887-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
SARS-CoV-2 Nucleocapsid Mosaic Recombinant protein His Tag |
|
ICOV2NTMOSAICRHIS50UG |
Innovative research |
each |
EUR 648 |
|
|
|
Description: SARS-CoV-2 Nucleocapsid Mosaic Recombinant protein His Tag |
SARS-CoV-2 Nucleocapsid Mosaic Recombinant protein His Tag |
|
MBS8430848-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
SARS, Spike Protein, Mosaic (CT), Recombinant (Severe Acute Respiratory Syndrome, SARS-CoV, SARS Associated Coronavirus) |
|
MBS635500-1mg |
MyBiosource |
1mg |
EUR 1930 |
SARS, Spike Protein, Mosaic (CT), Recombinant (Severe Acute Respiratory Syndrome, SARS-CoV, SARS Associated Coronavirus) |
|
MBS635500-5x1mg |
MyBiosource |
5x1mg |
EUR 8540 |
SARS-CoV-2 (COVID-19) Spike E Mosaic Recombinant protein |
|
39-114 |
ProSci |
0.05 mg |
EUR 556.8 |
|
Description: A human infecting coronavirus (viral pneumonia) called 2019 novel coronavirus, 2019-nCoV was found in the fish market at the city of Wuhan, Hubei province of China on December 2019. The 2019-nCoV shares an 87% identity to the 2 bat-derived severe acute respiratory syndrome 2018 SARS-CoV-2 located in Zhoushan of eastern China. 2019-nCoV has an analogous receptor-BD-structure to that of 2018 SARS-CoV, even though there is a.a. diversity so thus the 2019-nCoV might bind to ACE2 receptor protein (angiotensin-converting enzyme 2) Â in humans. While bats are possibly the host of 2019-nCoV, researchers suspect that animal from the ocean sold at the seafood market was an intermediate host. RSCU analysis proposes that the 2019-nCoV is a recombinant within the viral spike glycoprotein between the bat coronavirus and an unknown coronavirus. |
SARS-CoV-2 (COVID-19) Nucleocapsid Mosaic Recombinant protein |
|
39-115 |
ProSci |
0.05 mg |
EUR 556.8 |
|
Description: A human infecting coronavirus (viral pneumonia) called 2019 novel coronavirus, 2019-nCoV was found in the fish market at the city of Wuhan, Hubei province of China on December 2019. The 2019-nCoV shares an 87% identity to the 2 bat-derived severe acute respiratory syndrome 2018 SARS-CoV-2 located in Zhoushan of eastern China. 2019-nCoV has an analogous receptor-BD-structure to that of 2018 SARS-CoV, even though there is a.a. diversity so thus the 2019-nCoV might bind to ACE2 receptor protein (angiotensin-converting enzyme 2) Â in humans. While bats are possibly the host of 2019-nCoV, researchers suspect that animal from the ocean sold at the seafood market was an intermediate host. RSCU analysis proposes that the 2019-nCoV is a recombinant within the viral spike glycoprotein between the bat coronavirus and an unknown coronavirus. |
SARS Coronavirus Spike Glycoprotein (S1) Mosaic (N-Term) (E. coli) |
|
REC31840-100 |
The Native Antigen Company |
0.1 |
EUR 415.88 |
|
|
|
Description: Recombinant protein manufactured in E. coli. Contains the N-terminal section of the Spike protein immunodominant regions (aa 1-53, 90-115, 171-205). Immunoreactive with sera from SARS-infected individuals. |
SARS Coronavirus Spike Glycoprotein (S1) Mosaic (N-Term) (E. coli) |
|
REC31840-500 |
The Native Antigen Company |
0.5 |
EUR 1560.53 |
|
|
|
Description: Recombinant protein manufactured in E. coli. Contains the N-terminal section of the Spike protein immunodominant regions (aa 1-53, 90-115, 171-205). Immunoreactive with sera from SARS-infected individuals. |
SARS Coronavirus Spike Glycoprotein (S2) Mosaic (C-Term) (E. coli) |
|
REC31841-100 |
The Native Antigen Company |
0.1 |
EUR 415.88 |
|
|
|
Description: Recombinant protein manufactured in E. coli. Contains the C-terminal section of the Spike protein immunodominant regions. Immunoreactive with sera from SARS-infected individuals. |
SARS Coronavirus Spike Glycoprotein (S2) Mosaic (C-Term) (E. coli) |
|
REC31841-500 |
The Native Antigen Company |
0.5 |
EUR 1560.53 |
|
|
|
Description: Recombinant protein manufactured in E. coli. Contains the C-terminal section of the Spike protein immunodominant regions. Immunoreactive with sera from SARS-infected individuals. |
SARS-CoV-2 Spike-E-M Mosaic Protein, His-tag (E. coli) |
|
REC31829-100 |
The Native Antigen Company |
0.1 |
EUR 427.47 |
|
|
|
Description: Recombinant protein containing Spike (S), Envelope (E) and Membrane (M) immunodominant regions. Expressed and purified in E. coli with C-terminal His-tag. |
SARS-CoV-2 Spike-E-M Mosaic Protein, His-tag (E. coli) |
|
REC31829-500 |
The Native Antigen Company |
0.5 |
EUR 1628.77 |
|
|
|
Description: Recombinant protein containing Spike (S), Envelope (E) and Membrane (M) immunodominant regions. Expressed and purified in E. coli with C-terminal His-tag. |
SARS-CoV-2 Spike Mosaic Recombinant protein (C-terminus) Liquid |
|
ICOV2SPIKEMOSAICRCT100UG |
Innovative research |
each |
EUR 648 |
|
|
|
Description: SARS-CoV-2 Spike Mosaic Recombinant protein (C-terminus) Liquid |
SARS-CoV-2 Spike Mosaic Recombinant protein (N-terminus) Liquid |
|
ICOV2SPIKEMOSAICRNT100UG |
Innovative research |
each |
EUR 648 |
|
|
|
Description: SARS-CoV-2 Spike Mosaic Recombinant protein (N-terminus) Liquid |
SARS-CoV-2 Spike Mosaic Recombinant protein (C-terminus) Liquid |
|
MBS8430891-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
SARS-CoV-2 Spike Mosaic Recombinant protein (N-terminus) Liquid |
|
MBS8430892-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
Recombinant SARS Spike Mosaic S Protein (aa 12-53, 90-115, 171-203) |
|
VAng-Lsx0055-inquire |
Creative Biolabs |
inquire |
Ask for price |
|
Description: Recombinant SARS-CoV Spike protein containing 12-53, 90-115, 171-203 amino acids immunodominant regions was expressed in E. coli and purified by proprietary chromatographic technique. |
Recombinant SARS Spike Mosaic S Protein (aa 1051-1076, 1121-1154, 1162-1190) |
|
VAng-Lsx0057-inquire |
Creative Biolabs |
inquire |
Ask for price |
|
Description: Recombinant SARS-CoV Spike protein containing 1051-1076, 1121-1154, 1162-1190 amino acids immunodominant regions was expressed in E. coli and purified by proprietary chromatographic technique. |
SARS, Spike Protein, Mosaic (M), Recombinant (aa408-470, 540-573) (Severe Acute Respiratory Syndrome, SARS-CoV, SARS Associated Coronavirus) |
|
MBS637395-01mg |
MyBiosource |
0.1mg |
EUR 490 |
SARS, Spike Protein, Mosaic (M), Recombinant (aa408-470, 540-573) (Severe Acute Respiratory Syndrome, SARS-CoV, SARS Associated Coronavirus) |
|
MBS637395-05mg |
MyBiosource |
0.5mg |
EUR 1065 |
SARS, Spike Protein, Mosaic (M), Recombinant (aa408-470, 540-573) (Severe Acute Respiratory Syndrome, SARS-CoV, SARS Associated Coronavirus) |
|
MBS637395-5x05mg |
MyBiosource |
5x0.5mg |
EUR 4635 |
SARS, Spike Protein, Mosaic (N), Recombinant (aa12-53, 90-115, 171-203) (Severe Acute Respiratory Syndrome, SARS-CoV, SARS Associated Coronavirus) |
|
MBS636282-01mg |
MyBiosource |
0.1mg |
EUR 490 |
SARS, Spike Protein, Mosaic (N), Recombinant (aa12-53, 90-115, 171-203) (Severe Acute Respiratory Syndrome, SARS-CoV, SARS Associated Coronavirus) |
|
MBS636282-05mg |
MyBiosource |
0.5mg |
EUR 1065 |
SARS, Spike Protein, Mosaic (N), Recombinant (aa12-53, 90-115, 171-203) (Severe Acute Respiratory Syndrome, SARS-CoV, SARS Associated Coronavirus) |
|
MBS636282-5x05mg |
MyBiosource |
5x0.5mg |
EUR 4635 |
SARS, Spike Protein, Mosaic (C), Recombinant (aa1051-1076, 1121-1154, 1162-1190) (Severe Acute Respiratory Syndrome, SARS-CoV, SARS Associated Coronavirus) |
|
MBS636727-01mg |
MyBiosource |
0.1mg |
EUR 490 |
SARS, Spike Protein, Mosaic (C), Recombinant (aa1051-1076, 1121-1154, 1162-1190) (Severe Acute Respiratory Syndrome, SARS-CoV, SARS Associated Coronavirus) |
|
MBS636727-05mg |
MyBiosource |
0.5mg |
EUR 1065 |
SARS, Spike Protein, Mosaic (C), Recombinant (aa1051-1076, 1121-1154, 1162-1190) (Severe Acute Respiratory Syndrome, SARS-CoV, SARS Associated Coronavirus) |
|
MBS636727-5x05mg |
MyBiosource |
5x0.5mg |
EUR 4635 |
SARS-Associated Coronavirus Spike mosaic recombinant antigen S(M) a.a. 408-470/540-573. |
|
00196-V |
Virogen |
1 MG |
EUR 850 |
SARS-Associated Coronavirus Spike mosaic recombinant antigen S(M) a.a. 408-470/540-573. |
|
00196-V-100ugvial |
Virogen |
100 ug/vial |
EUR 150 |
|
|
|
Description: SARS-Associated Coronavirus Spike mosaic recombinant antigen S(M) a.a. 408-470/540-573. |
SARS-Associated Coronavirus Spike mosaic recombinant antigen S(M) a.a. 408-470/540-573. |
|
MBS485198-01mg |
MyBiosource |
0.1mg |
EUR 300 |
SARS-Associated Coronavirus Spike mosaic recombinant antigen S(M) a.a. 408-470/540-573. |
|
MBS485198-1mg |
MyBiosource |
1mg |
EUR 1300 |
SARS-Associated Coronavirus Spike mosaic recombinant antigen S(M) a.a. 408-470/540-573. |
|
MBS485198-5x1mg |
MyBiosource |
5x1mg |
EUR 5795 |
SARS-Associated Coronavirus Spike mosaic recombinant antigen S(M) a.a. 408-470/540-573. |
|
00196-V-01 |
Virogen |
100 µg |
Ask for price |
SARS-Associated Coronavirus Spike mosaic recombinant antigen S(M) a.a. 408-470/540-573. |
|
00196-V-02 |
Virogen |
1 mg |
Ask for price |
SARS-Associated Coronavirus Spike mosaic recombinant antigen S(N) a.a. 12-53/90-115/171-203. |
|
00195-V |
Virogen |
1 MG |
EUR 850 |
SARS-Associated Coronavirus Spike mosaic recombinant antigen S(N) a.a. 12-53/90-115/171-203. |
|
00195-V-100ugvial |
Virogen |
100 ug/vial |
EUR 150 |
|
|
|
Description: SARS-Associated Coronavirus Spike mosaic recombinant antigen S(N) a.a. 12-53/90-115/171-203. |
SARS-Associated Coronavirus Spike mosaic recombinant antigen S© a.a. 1051-1076/1121-1154/1162-1190. |
|
00197-V |
Virogen |
1 MG |
EUR 850 |
SARS-Associated Coronavirus Spike mosaic recombinant antigen S© a.a. 1051-1076/1121-1154/1162-1190. |
|
00197-V-100ugvial |
Virogen |
100 ug/vial |
EUR 150 |
|
Description: SARS-Associated Coronavirus Spike mosaic recombinant antigen S© a.a. 1051-1076/1121-1154/1162-1190. |
SARS-Associated Coronavirus Spike mosaic recombinant antigen S(N) a.a. 12-53/90-115/171-203. |
|
MBS485108-01mg |
MyBiosource |
0.1mg |
EUR 300 |
SARS-Associated Coronavirus Spike mosaic recombinant antigen S(N) a.a. 12-53/90-115/171-203. |
|
MBS485108-1mg |
MyBiosource |
1mg |
EUR 1300 |
SARS-Associated Coronavirus Spike mosaic recombinant antigen S(N) a.a. 12-53/90-115/171-203. |
|
MBS485108-5x1mg |
MyBiosource |
5x1mg |
EUR 5795 |
SARS-Associated Coronavirus Spike mosaic recombinant antigen S© a.a. 1051-1076/1121-1154/1162-1190. |
|
MBS485135-01mg |
MyBiosource |
0.1mg |
EUR 300 |
SARS-Associated Coronavirus Spike mosaic recombinant antigen S© a.a. 1051-1076/1121-1154/1162-1190. |
|
MBS485135-1mg |
MyBiosource |
1mg |
EUR 1300 |
SARS-Associated Coronavirus Spike mosaic recombinant antigen S© a.a. 1051-1076/1121-1154/1162-1190. |
|
MBS485135-5x1mg |
MyBiosource |
5x1mg |
EUR 5795 |
SARS-Associated Coronavirus Spike mosaic recombinant antigen S(N) a.a. 12-53/90-115/171-203. |
|
00195-V-01 |
Virogen |
100 µg |
Ask for price |
SARS-Associated Coronavirus Spike mosaic recombinant antigen S(N) a.a. 12-53/90-115/171-203. |
|
00195-V-02 |
Virogen |
1 mg |
Ask for price |
SARS-Associated Coronavirus Spike mosaic recombinant antigen S (C) a.a. 1051-1076/1121-1154/1162-1190. |
|
00197-V-01 |
Virogen |
100 µg |
Ask for price |
SARS-Associated Coronavirus Spike mosaic recombinant antigen S (C) a.a. 1051-1076/1121-1154/1162-1190. |
|
00197-V-02 |
Virogen |
1 mg |
Ask for price |
Coronavirus, SARS Associated, Nucleocapsid, Mosaic, Recombinant (aa1-49, 192-220) (Severe Acute Respiratory Syndrome) |
|
MBS636445-01mg |
MyBiosource |
0.1mg |
EUR 490 |
Coronavirus, SARS Associated, Nucleocapsid, Mosaic, Recombinant (aa1-49, 192-220) (Severe Acute Respiratory Syndrome) |
|
MBS636445-05mg |
MyBiosource |
0.5mg |
EUR 1065 |
Coronavirus, SARS Associated, Nucleocapsid, Mosaic, Recombinant (aa1-49, 192-220) (Severe Acute Respiratory Syndrome) |
|
MBS636445-5x05mg |
MyBiosource |
5x0.5mg |
EUR 4635 |
CMV Mosaic |
|
cmv-217 |
ProSpec Tany |
100µg |
EUR 165 |
|
Description: Recombinant Cytomegalo Virus Mosaic |
EBV Mosaic |
|
ebv-275 |
ProSpec Tany |
100µg |
EUR 165 |
|
Description: Recombinant Epstein-Barr Virus (HHV-4) Mosaic p18 |
Plasmodium Falciparum Cs Mosaic Recombinant (PfCs Mosaic) |
|
PT_41736 |
Novatein Biosciences, Inc. |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
Rubella Mosaic |
|
rub-291 |
ProSpec Tany |
100µg |
EUR 165 |
|
Description: Recombinant Rubella Virus E1 Mosaic |
Treponema Mosaic |
|
trp-276 |
ProSpec Tany |
100µg |
EUR 200 |
|
Description: Recombinant Treponema pallidum Mosaic |
Treponema pallidum p41 Mosaic Recombinant (T.pallidum p41 Mosaic) |
|
PT_42176 |
Novatein Biosciences, Inc. |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
Hepatitis C Virus NS4 Mosaic Recombinant (HCV NS4 Mosaic) |
|
PT_40896 |
Novatein Biosciences, Inc. |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
Hepatitis E Virus Mosaic-S Recombinant (HEV Mosaic-S) |
|
PT_40938 |
Novatein Biosciences, Inc. |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
HCV Mosaic-A |
|
hcv-001 |
ProSpec Tany |
100µg |
EUR 165 |
|
Description: Recombinant Hepatitis C Virus Mosaic Antigen-A |
HCV Mosaic-B |
|
hcv-002 |
ProSpec Tany |
100µg |
EUR 165 |
|
Description: Recombinant Hepatitis C Virus Mosaic Antigen-B |
HCV NS4 Mosaic |
|
hcv-205 |
ProSpec Tany |
100µg |
EUR 165 |
|
Description: Recombinant Hepatitis C Virus NS4 Mosaic |
HSV-8 Mosaic |
|
hsv-225 |
ProSpec Tany |
100µg |
EUR 165 |
|
Description: Recombinant Herpes Simplex Virus-8 Mosaic |
Mosaic cytomegalovirus |
|
MBS596105-1mg |
MyBiosource |
1mg |
EUR 425 |
Mosaic cytomegalovirus |
|
MBS596105-2mg |
MyBiosource |
2mg |
EUR 700 |
Mosaic cytomegalovirus |
|
MBS596105-5mg |
MyBiosource |
5mg |
EUR 1505 |
HTLV-1 Mosaic |
|
hiv-144 |
ProSpec Tany |
100µg |
EUR 165 |
|
Description: Recombinant HTLV-1 Mosaic |
EBV EBNA1 Mosaic |
|
ebv-271 |
ProSpec Tany |
100µg |
EUR 165 |
|
Description: Recombinant Epstein-Barr Virus (HHV-4) EBNA1 Mosaic |
Hepatitis C Virus Mosaic Antigen-B Recombinant (HCV Mosaic-B) |
|
PT_73803 |
Novatein Biosciences, Inc. |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
Hepatitis C Virus Mosaic Antigen-A Recombinant (HCV Mosaic-A) |
|
PT_73804 |
Novatein Biosciences, Inc. |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
HIV-1 gp120 Nef Mosaic Recombinant (HIV-1 gp120 Nef Mosaic) |
|
PT_40963 |
Novatein Biosciences, Inc. |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
Treponema p41 Mosaic |
|
trp-244 |
ProSpec Tany |
100µg |
EUR 165 |
|
Description: Recombinant Treponema pallidum p41 Mosaic |
Cytomegalo Virus Mosaic |
|
MBS555860-01mg |
MyBiosource |
0.1mg |
EUR 340 |
Cytomegalo Virus Mosaic |
|
MBS555860-05mg |
MyBiosource |
0.5mg |
EUR 810 |
Cytomegalo Virus Mosaic |
|
MBS555860-5x05mg |
MyBiosource |
5x0.5mg |
EUR 3495 |
Cytomegalo Virus Mosaic |
|
PR27123 |
Neuromics |
500 ug |
EUR 197.1 |
Cytomegalo Virus Mosaic |
|
PR27123-B |
Neuromics |
each |
EUR 540 |
TREPONEMA PALLIDUM MOSAIC |
|
GWB-96D8B3 |
GenWay Biotech |
1 mg |
Ask for price |
Mosaic HIV1/2 antigen |
|
MBS596015-1mg |
MyBiosource |
1mg |
EUR 340 |
Mosaic HIV1/2 antigen |
|
MBS596015-2mg |
MyBiosource |
2mg |
EUR 505 |
Mosaic HIV1/2 antigen |
|
MBS596015-5mg |
MyBiosource |
5mg |
EUR 1025 |
HTLV-1 Mosaic Protein |
|
20-abx260286 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
|
HTLV-1 Mosaic Protein |
|
abx260286-25g |
Abbexa |
25 µg |
EUR 950 |
HTLV-1 Mosaic Protein |
|
abx260286-5g |
Abbexa |
5 µg |
EUR 350 |
Rubella Virus E1 Mosaic |
|
MBS555862-01mg |
MyBiosource |
0.1mg |
EUR 340 |
Rubella Virus E1 Mosaic |
|
MBS555862-05mg |
MyBiosource |
0.5mg |
EUR 810 |
Rubella Virus E1 Mosaic |
|
MBS555862-5x05mg |
MyBiosource |
5x0.5mg |
EUR 3495 |
Rubella Virus E1 Mosaic |
|
PR27125 |
Neuromics |
500 ug |
EUR 197.1 |
Rubella Virus E1 Mosaic |
|
PR27125-B |
Neuromics |
each |
EUR 540 |
CMV gB mosaic 39 kDa |
|
PR-1444-L |
Jena Bioscience GmbH |
1mg |
EUR 1480.78 |
|
Description: recombinant, E. coli |
CMV gB mosaic 39 kDa |
|
PR-1444-S |
Jena Bioscience GmbH |
200µg |
EUR 370.29 |
|
Description: recombinant, E. coli |
Malaria Cs Mosaic Protein |
|
20-abx260295 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
|
HCV NS4 mosaic 70 kDa |
|
PR-1410-L |
Jena Bioscience GmbH |
1mg |
EUR 988.32 |
|
Description: recombinant, E. coli |
HCV NS4 mosaic 70 kDa |
|
PR-1410-S |
Jena Bioscience GmbH |
200µg |
EUR 246.99 |
|
Description: recombinant, E. coli |
Tp TmpA mosaic 32 kDa |
|
PR-1424-L |
Jena Bioscience GmbH |
1mg |
EUR 988.32 |
|
Description: recombinant, E. coli |
Tp TmpA mosaic 32 kDa |
|
PR-1424-S |
Jena Bioscience GmbH |
200µg |
EUR 246.99 |
|
Description: recombinant, E. coli |
HCV core mosaic 33 kDa |
|
PR-1404-L |
Jena Bioscience GmbH |
1mg |
EUR 988.32 |
|
Description: recombinant, E. coli |
HCV core mosaic 33 kDa |
|
PR-1404-S |
Jena Bioscience GmbH |
200µg |
EUR 246.99 |
|
Description: recombinant, E. coli |
Recombinant HTLV-1 Mosaic |
|
7-07773 |
CHI Scientific |
1000µg |
Ask for price |
Recombinant HTLV-1 Mosaic |
|
MBS142628-01mg |
MyBiosource |
0.1mg |
EUR 330 |
Recombinant HTLV-1 Mosaic |
|
MBS142628-05mg |
MyBiosource |
0.5mg |
EUR 825 |
Recombinant HTLV-1 Mosaic |
|
MBS142628-1mg |
MyBiosource |
1mg |
EUR 1515 |
Recombinant HTLV-1 Mosaic |
|
MBS142628-5x1mg |
MyBiosource |
5x1mg |
EUR 6485 |
Hepatitis C Virus NS4 Mosaic Genotype-5 Recombinant (HCV NS4 Mosaic Genotype-5) |
|
PT_40894 |
Novatein Biosciences, Inc. |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
Hepatitis C Virus NS4 Mosaic Genotype-1 Recombinant (HCV NS4 Mosaic Genotype-1) |
|
PT_40897 |
Novatein Biosciences, Inc. |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
Hepatitis C Virus NS4 Mosaic Genotype-2 Recombinant (HCV NS4 Mosaic Genotype-2) |
|
PT_40898 |
Novatein Biosciences, Inc. |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
Hepatitis C Virus NS4 Mosaic Genotype-3 Recombinant (HCV NS4 Mosaic Genotype-3) |
|
PT_40899 |
Novatein Biosciences, Inc. |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
Recombinant Malaria Cs Mosaic |
|
7-07090 |
CHI Scientific |
100µg |
Ask for price |
Recombinant Malaria Cs Mosaic |
|
7-07091 |
CHI Scientific |
500µg |
Ask for price |
Recombinant Malaria Cs Mosaic |
|
7-07092 |
CHI Scientific |
1000µg |
Ask for price |
Malaria Cs Mosaic (Recombinant) |
|
22060547-1 |
Bio-WORLD |
100 µg |
EUR 344.89 |
The regular states of the mannequin are analyzed and the sensitivity evaluation of the fundamental reproductive quantity is explored. Furthermore to parameterize the mannequin an actual knowledge of SARS-CoV-2 virus reported within the Sultanate of Oman from January 1st, 2021 to Could 23rd, 2021 are used. We then carry out the massive scale numerical findings to point out the validity of the analytical work.